ALB and familial pancreatic carcinoma: Our study presents a novel approach to addressing the challenges in pancreatic cancer treatment by combining albumin-based nanoparticles (BCP) with a thermosensitive PLGA-PEG-PLGA hydrogel for localized drug delivery.